Free Trial
LON:LABS

Life Science REIT (LABS) Share Price, News & Analysis

Life Science REIT logo
GBX 43 -0.20 (-0.46%)
As of 11:52 AM Eastern

About Life Science REIT Stock (LON:LABS)

Key Stats

Today's Range
43
43.50
50-Day Range
41.20
48.60
52-Week Range
31.30
49
Volume
422,586 shs
Average Volume
766,039 shs
Market Capitalization
£152.66 million
P/E Ratio
N/A
Dividend Yield
4.65%
Price Target
GBX 46.50
Consensus Rating
Moderate Buy

Company Overview

Life Science REIT Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
12th Percentile Overall Score

LABS MarketRank™: 

Life Science REIT scored higher than 12% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Life Science REIT has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Life Science REIT has received no research coverage in the past 90 days.

  • Read more about Life Science REIT's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Life Science REIT is -3.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Life Science REIT is -3.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Life Science REIT has a P/B Ratio of 0.56. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for LABS.
  • Dividend Leadership

    Life Science REIT is a leading dividend payer. It pays a dividend yield of 5.67%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    Life Science REIT does not have a long track record of dividend growth.

  • Read more about Life Science REIT's dividend.
  • Short Interest

    There is no current short interest data available for LABS.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Life Science REIT this week, compared to 0 articles on an average week.
  • Search Interest

    1 people have searched for LABS on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Life Science REIT insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 6.96% of the stock of Life Science REIT is held by insiders.

  • Percentage Held by Institutions

    67.27% of the stock of Life Science REIT is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Life Science REIT's insider trading history.
Receive LABS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Life Science REIT and its competitors with MarketBeat's FREE daily newsletter.

LABS Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

LABS Stock Analysis - Frequently Asked Questions

Life Science REIT's stock was trading at GBX 38 at the beginning of the year. Since then, LABS shares have increased by 13.2% and is now trading at GBX 43.

Life Science REIT plc (LON:LABS) released its earnings results on Wednesday, April, 16th. The company reported $1.70 earnings per share for the quarter. Life Science REIT had a negative net margin of 198.99% and a negative trailing twelve-month return on equity of 14.53%.

Shares of LABS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Company Calendar

Last Earnings
4/16/2025
Today
7/15/2025

Industry, Sector and Symbol

Stock Exchange
LON
Industry
REIT - Healthcare Facilities
Sub-Industry
N/A
Current Symbol
LON:LABS
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

High Price Target
GBX 57
Low Price Target
GBX 36
Potential Upside/Downside
+8.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
GBX (11.28)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£40.62 million
Net Margins
-198.99%
Pretax Margin
N/A
Return on Equity
-14.53%
Return on Assets
1.25%

Debt

Debt-to-Equity Ratio
44.18
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
£20.41 million
Price / Sales
7.49
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
GBX 76.35 per share
Price / Book
0.56

Miscellaneous

Outstanding Shares
355,028,736
Free Float
N/A
Market Cap
£152.84 million
Optionable
Not Optionable
Beta
0.08
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (LON:LABS) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners